OP 2507

Drug Profile

OP 2507

Alternative Names: ONO 2507

Latest Information Update: 04 Oct 2000

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dainippon Pharmaceutical; Ono Pharmaceutical
  • Class Anti-ischaemics; Hepatoprotectants; Prostaglandins; Small molecules
  • Mechanism of Action Epoprostenol agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cerebrovascular disorders; Liver disorders; Reperfusion injury

Most Recent Events

  • 04 Oct 2000 Two preclinical studies have been added to the Transplant Rejection and Vascular Disorders pharmacodynamics sections ,
  • 14 Jun 2000 Discontinued-Preclinical for Reperfusion injury in Japan (IV)
  • 30 May 2000 Discontinued-II for Liver disorders prevention in Japan (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top